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Solitary ﬁbrous tumors are well described in the pleura, but rare extra-pleural neoplasms have been
reported. We describe a patient with a solitary left renal ﬁbrous tumor who after undergoing a ne-
phrectomy, presented 8 years later with a contralateral metachronous solitary ﬁbrous tumor. Malignant
metastatic extra-pleural solitary ﬁbrous tumors are extremely rare, and to our knowledge, this is the ﬁrst
case of contralateral recurrence of solitary renal ﬁbrous tumor. The patient underwent a robotic assisted
partial nephrectomy of the right renal mass. Both tumors showed overlapping histopathology.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Solitary ﬁbrous tumors are most commonly described in the
pleura but extra-pleural cases have been identiﬁed, rarely occurring
in the kidney. Solitary ﬁbrous tumors most commonly carry a
benign course. Malignant cases are pathologically characterized by
high cellularity, >10 mitotic ﬁgures per 10 HPF, pleomorphism,
hemorrhage and necrosis and tend to metastasize and limit patient
survival.1 Patients with benign lesions are usually cured by simple
excision whereas only half of those with malignant tumors are
cured this way.1
We present here the ﬁrst case of contralateral recurrent malig-
nant solitary ﬁbrous tumor of the kidney.Case presentation
A 49-year-old female who presented to our institution with
vague abdominal pain, nausea, and a 15 lbs weight loss was found
to have a 19  12  10 cm left enhancing renal mass with centralmography; HPF, High Power
; SFT, solitary ﬁbrous tumor.
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access article under the CC BY-NCnecrosis and calciﬁcations on abdominal CT scan (Fig.1). The patient
underwent left renal artery embolization by interventional radi-
ology followed by a left radical nephrectomy with retroperitoneal
lymphadenectomy. Pathologic evaluation revealed a 16 119 cm
solitary ﬁbrous tumor involving the perinephric soft tissue of the
renal hilum, renal capsule, serosa of the ureter, and renal pelvis
without lymphovascular invasion or nodal involvement (0 out of 35
lymph nodes). On immunohistochemical staining, the neoplastic
cells were strongly positive for CD34 (>50%), and weakly focally
positive for ER (10%), and PR (5%). They were negative for keratins
AE1/AE3, CK 7, CK20, EMA, P63, CD10, HMB 45, Melan-A, and CD117.
SMA showed focal positivity and the tumor had 5 mitoses per 10
HPF.
Eight years after the initial operation, a follow up CT scan
revealed a 4.3 cm exophytic, low complexity, enhancing solid mass
with cystic and necrotic foci occupying the lower pole of the right
kidney highly suspicious for malignancy (Fig. 2). A robotic assisted
laparoscopic right partial nephrectomy was performed without
complication. H&E staining showed a cellular spindle cell neoplasm
with an elevated mitotic rate up to 6 mitoses in 10 HPF, signiﬁcant
cytologic atypia, and regions of necrosis. Immunohistochemistry
revealed that tumor cells were positive for CD34 (w10%), diffuse
CD99 (Fig. 3), diffuse BCL-2 and vimentin. The case was compared
to the prior contralateral renal tumor and showed overlapping
histomorphology. Follow up CT imaging 18 months post-op-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Large 12 cm  10 cm enhancing left renal mass with central necrosis and
calciﬁcation on initial presentation (black arrow).
Figure 3. Histopathology of the resected metachronous right kidney lesion revealing
spindle cell architecture, cytological atypia, and diffuse CD 99 staining on immuno-
histochemistry consistent with malignant SFT.
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remained stable (Cr 1.07 mg/dL, GFR 58 mL/min/1.73 m2 based on
MDRD).Discussion
Solitary ﬁbrous tumors, also known as hemangiopericytomas,
are usually benign and arise from mesenchymal spindle cells
typically from the pleura. Extra-pleural sites have been described
and the behavior of these SFTs can be unpredictable and may arise
in different parts of the body with the ﬁrst renal site reported by
Gelb et al in 1996.2While close to 50 cases of renal SFTare described
in literature, malignant disease still remains extremely rare with
only 8 other cases described, and none to our knowledge presented
with metachronous spread to the contralateral kidney (Table 1).
Solitary ﬁbrous tumor of the kidney has been described as
originating from the renal capsule, and thus sarcomatoid RCC is
often in the differential.5 Immunohistochemically, SFT stain positive
for CD34 in a majority of the cases (sensitivity >90%), BCL-2 in
about 50% of the time, and vimentin in 20%.3 However, withFigure 2. Eight years post left radical nephrectomy with new 4.3 cm enhancing right
renal mass with necrotic foci (black arrow).malignant transformation, SFT may lose CD34 expression and
staining as described by Sasaki, et al in which the primary resected
renal tumor stained CD34 positive, but negative in the distant
metastatic liver site and weakly positive in the pleural site.3
Pathophysiologic mechanisms for malignant transformation of
SFT have been postulated in literature but difﬁcult to prove due to
lack of large scale studies. The two ideas proposed are 1) de novo
occurrence and 2) dedifferentiation from pre-existing benign SFT.3
Because our case shows a decrease in the CD34 staining while
remaining morphologically similar in the recurrent contralateral
tumor compared to the original lesion, sarcomatous dedifferentia-
tion is a feasible mechanism of transformation.
Given the ﬁndings in the recurrent right side tumor of hyper-
cellularity, pleomorphism, and 6 mitoses/10 HPF in our case, this
tumor fulﬁlls most criteria for malignant SFT (high cellularity,
pleomorphism, dedifferentiation, mitosis >4 per 10 HPF, size
exceeding 10 cm, and abnormal sites of presentation for pleural and
extra-pleural malignant solitary ﬁbrous tumors).1 SFTs are also
known to occur in unusual visceral sites such as pancreas, prostate,
spermatic cord and diaphragm with similarly unusual metastatic
spread described to omentum, peritoneum, subcutaneous tissues
and colonic mesentery.4 In a series of 79 patients with SFTs (pleural
and extra-pleural), 16 patients (20%) had malignant components.
None of these patients were described as having multi-focal pri-
mary SFTs.4 Therefore, it does not appear that a subset of patients
exist with a genetic predisposition to recurrent primary SFT. Given
the similar histomorphology of the original tumor and contralateral
recurrence, the size of the original tumor increasing the risk of
metastasis and the propensity of SFTs to spread to unusual sites, we
believe this case to be consistent with a metastasis and less likely to
represent multi-focal tumor.Table 1
Review of reported malignant renal SFT s/p nephrectomy
Case Reference Year Age Sex Size (cm) Outcome
1 Fine et al3 2006 76 M 12 Persistent disease
2 Magro et al 2008 34 F 9 Disease free
3 Marzi et al 2011 72 F 19 Unknown
4 Hsieh et al 2011 50 F 9 Disease free
5 De Martino et al 2012 68 F 7 Disease speciﬁc death
6 Cuello & Brugés 2012 49 F 9.8 Stable disease
7 Sasaki et al4 2013 48 M 28 Disease free
8 Mearini et al 2014 19 F 17 Disease free
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In summary, we report a case of isolated recurrent malignant
SFT arising in the right kidney 8 years after nephrectomy for SFT of
the contralateral side likely representing metastatic spread. Meta-
chronous lesions of solitary ﬁbrous tumors suggest malignant po-
tential in a tumor otherwise considered to be benign in majority of
cases. These ﬁndings may play signiﬁcant impact in patient man-
agement as providers should council patients with high risk path-
ologic features as to the need for surveillance. Based on ﬁndings
from our study as well as prior case reports, we propose for SFTs
meeting malignant criteria, a surveillance protocol similar to the
current NCCN guidelines for other renal malignancies e at mini-
mum a yearly clinical evaluation with chest and abdominal axial
imaging. With reports describing malignant recurrence of SFTs
anywhere from 8e20 years from initial diagnosis, we propose
continuing follow up long term. Malignant SFT cases are rare and
future studies will be necessary to elucidate follow up guidelines for
surveillance.Conﬂict of interest
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